Sacral Neuromodulation for Male Overactive Bladder (MOAB)

To assess the post-market clinical outcomes of the Axonics SNM System for treatment of overactive bladder in male patients.

Trial Details

NCT ID
NCT06511141
Phase
NA
Sponsor
Axonics, Inc.
Status
RECRUITING
Cancer Type
Prostate Cancer
Interventions
  • Axonics SNM System
Locations (sample)
  • Birmingham, Alabama, United States|33.52066,-86.80249
  • Fairhope, Alabama, United States|30.52297,-87.90333
  • Scottsdale, Arizona, United States|33.50921,-111.89903
  • Mountain View, California, United States|37.38605,-122.08385
  • Murrieta, California, United States|33.55391,-117.21392

Key Eligibility Criteria

  • Participants aged ≥ 18 years at the time of enrollment
  • Able to complete bladder diaries and patient questionnaires
  • Primary diagnosis of OAB (urinary urgency incontinence (UUI) or urinary frequency (UF)).
  • Willing and capable to provide written informed consent and agrees to comply with specified evaluations at clinical investigational sites and atten…

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Prostate Cancer Trials on Trialify →